Literature DB >> 12560676

Frontoethmoidal encephalomeningocele: surgical correction by the Chula technique.

Charan Mahatumarat1, Nond Rojvachiranonda, Chopoew Taecholarn.   

Abstract

This study reevaluates a surgical technique known as the Chula technique, previously reported in 1991 for correction of frontoethmoidal encephalomeningocele. From 1986 to 1999, 108 patients were operated on with this technique, which could remove the herniation mass, repair dural and bone defects, reconstruct the naso-orbital area, and restore aesthetic facial appearance in a single stage. Formal frontal craniotomy was not necessary. The result has been very satisfying in terms of safety, cure rate, and aesthetic outcome. Spontaneous improvement of lacrimal passage obstruction occurred in 85.2 percent of cases, and dacryocystorhinostomy was required in the rest. There was no mortality. Complications (e.g., wound infection, 6.5 percent; wire extrusion, 3.7 percent; meningitis, 2.8 percent; cerebrospinal fluid leakage, 2.8 percent; and postoperative increased intracranial pressure, 2.8 percent) were much less frequent than in other reports. With a mean follow-up period of 439 days (maximum, 12 years), there has been no recurrence.

Entities:  

Mesh:

Year:  2003        PMID: 12560676     DOI: 10.1097/01.PRS.0000040523.57406.94

Source DB:  PubMed          Journal:  Plast Reconstr Surg        ISSN: 0032-1052            Impact factor:   4.730


  15 in total

1.  Symptomatic epilepsy with a tumor in the nose.

Authors:  Lars Eichler; Werner J Z'Graggen; Marco Caversaccio; Matthias Sturzenegger
Journal:  J Neurol       Date:  2006-06-19       Impact factor: 4.849

2.  Naso-ethmoidal encephalocele with bilateral orbital extension: report of a case in a western country.

Authors:  Francesca Secci; Alessandro Consales; Paolo Merciadri; Giuseppe Marcello Ravegnani; Gianluca Piatelli; Marco Pavanello; Armando Cama
Journal:  Childs Nerv Syst       Date:  2013-06-19       Impact factor: 1.475

3.  Frontoethmoidal encephalocele: clinical presentation, diagnosis, treatment, and complications in 400 cases.

Authors:  Muhammad Arifin; Wihasto Suryaningtyas; Abdul Hafid Bajamal
Journal:  Childs Nerv Syst       Date:  2018-01-05       Impact factor: 1.475

Review 4.  Development of pediatric neurosurgical service at Dr. Soetomo Hospital, Surabaya, Indonesia.

Authors:  Wihasto Suryaningtyas; Muhammad Arifin; Agus Turchan; Abdul Hafid Bajamal
Journal:  Childs Nerv Syst       Date:  2017-07-10       Impact factor: 1.475

5.  Nasoethmoid-nasoorbital encephalocele presenting with orbital pulsation.

Authors:  Wihasto Suryaningtyas; Muhammad Arifin; Abdul Hafid Bajamal
Journal:  Childs Nerv Syst       Date:  2017-06-22       Impact factor: 1.475

6.  Treating nasoethmoidal encephalocele in a low-resource country: a surgical experience from a Philippine multidisciplinary craniofacial team.

Authors:  Dax Carlo G Pascasio; Rafael Denadai; Gerardo D Legaspi; Servando Andres Liban; Bernard U Tansipek
Journal:  Childs Nerv Syst       Date:  2019-05-26       Impact factor: 1.475

7.  Median facial cleft with a frontoethmoidal encephalocele treated with craniofacial bipartition and free radial forearm flap: a case report.

Authors:  Marton König; Bernt Due-Tønnessen; Terje Osnes; Jan-Ragnar Haugstvedt; Torstein R Meling
Journal:  Skull Base       Date:  2010-03

8.  Predictors of surgical approaches for the repair of anterior cranial base encephaloceles.

Authors:  Ramazan Gun; Fuat Tosun; Abdullah Durmaz; Ediz Yorgancilar; Salih Bakir; Kaan Kamasak; Cuneyt Gocmez
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-09-05       Impact factor: 2.503

9.  Frontoethmoidal encephalocele: Case report and review on management.

Authors:  Rajesh B Dhirawani; Richa Gupta; Sanyog Pathak; Gaurav Lalwani
Journal:  Ann Maxillofac Surg       Date:  2014 Jul-Dec

Review 10.  The extracranial versus intracranial approach In frontoethmoidal encephalocele corrective surgery: a meta-analysis.

Authors:  Wihasto Suryaningtyas; I Putu Ananta Wijaya Sabudi; Muhammad Arifin Parenrengi
Journal:  Neurosurg Rev       Date:  2021-06-13       Impact factor: 2.800

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.